Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scivation is a sports nutrition company best known for its flagship product line, Xtend, which pioneered the intra-workout Branched-Chain Amino Acid (BCAA) category. The company focuses on developing science-based supplements designed to enhance muscle recovery, hydration, and protein synthesis for athletes and fitness enthusiasts. Founded in 2004, Scivation built a reputation for transparency and efficacy in the nutraceutical space by utilizing clinically studied ingredients. In 2017, the company was acquired by Nutrabolt, the makers of Cellucor, to expand their portfolio of performance-driven health products. Today, Scivation continues to operate as a leading brand under the Nutrabolt umbrella, maintaining a dominant position in the global recovery supplement market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scivation.